Gitte Ørtoft - Gynecology

Author Information

Gitte Ørtoft is a researcher affiliated with the Department of Gynecology at Copenhagen University Hospital in Copenhagen, Denmark. Her work predominantly focuses on gynecological cancers, particularly endometrial cancer. With her extensive research and significant contributions, she has become a notable figure in her field.

Research Contributions

Gitte Ørtoft has made substantial contributions to the understanding and treatment of endometrial cancer. Her research spans various aspects of the disease, including lymph node staging, prognostic factors, preoperative predictions, and the impact of histological reviews. Her work has provided valuable insights into the management and outcomes of endometrial cancer, influencing clinical practices and improving patient care.

Aliases

Gitte Ørtoft is also known by the aliases G. Ørtoft and G Ørtoft in her publications.

Publication and Citation Metrics

Metric	Value
Total Citations	1942
H-Index	21
Number of Papers	65

Publications:

The 10-year results after national introduction of pelvic lymph node staging in Danish intermediate-risk endometrial cancer patients not given postoperative radiotherapy.

DOI: 10.1016/j.ejogrb.2021.06.040

Year: 2021

Prognostic impact of histological review of high-grade endometrial carcinomas in a large Danish cohort

DOI: 10.1007/s00428-021-03133-2

Year: 2021

Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer

DOI: 10.1097/PGP.0000000000000805

Year: 2021

Preoperative prediction of high-risk endometrial cancer by expert and non-expert transvaginal ultrasonography, magnetic resonance imaging, and endometrial histology.

DOI: 10.1016/j.ejogrb.2021.05.041

Year: 2021

Trends in hysterectomy‐corrected uterine cancer mortality rates during 2002 to 2015: mortality of nonendometrioid cancer on the rise?

DOI: 10.1002/ijc.33219

Year: 2020

Hysteroscopic resectoscope-directed biopsies and outpatient endometrial sampling for assessment of tumor histology in women with endometrial cancer or atypical hyperplasia.

DOI: 10.1016/j.ejogrb.2020.05.010

Year: 2020

Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study

DOI: 10.3802/jgo.2020.31.e22

Year: 2019

Identification of endometrial cancers and atypical hyperplasia: Development and validation of a simplified system for ultrasound scoring of endometrial pattern.

DOI: 10.1016/J.MATURITAS.2019.01.017

Year: 2019

Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study

DOI: 10.1136/ijgc-2018-000056

Year: 2019

Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study

DOI: 10.3802/jgo.2019.30.e84

Year: 2019

How is Chemoprevention Administered?

What Are Immunological Factors in Gynecology?

How Do Beneficial Bacteria Work?

How can hormonal contraceptives impact mood?

What are Assisted Reproductive Techniques?

When is Acyclovir Prescribed?

How is the DIEP Flap Procedure Performed?

How to Apply for Federal Direct Loans?

What is Gynecological Maintenance?

What are the guidelines for screening?

Partnered Content Networks

Relevant Topics